Saffron

Saffron

Best for

Lift and steady your mood

Large effect, needs confirmation · 28–60 mg/day for 6–8 weeks · 3 studies , n=189

58 papers · 13 claims · 152 outcomes scored · 12 positive

Outcomes

What saffron actually does, by outcome

Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.

Outcome Effect Evidence Dose Weeks Rank
Lift and steady your mood Large effect, needs confirmation
large
3 RCTs n=189 28–60 mg 6–8 wk #1/20
Reduce everyday pain intensity Large effect, needs confirmation
large
2 meta-analyses n=42 Meta-analyzed 15–100 mg 12 wk #10/55
Stay asleep through the night Likely benefit
moderate
4 meta-analyses n=405 Meta-analyzed 0.6–300 mg 4–6 wk #2/15
Lift mood and reduce negativity Promising early signal
moderate
2 RCTs n=169 28–30 mg 6–12 wk #2/6
Reduce emotional overwhelm Promising early signal
moderate
2 RCTs n=144 28 mg 6–12 wk #3/7
Ease depression symptoms Likely modest benefit
small
12 meta-analyses n=18k Meta-analyzed 0.6–300 mg 4–48 wk #2/41
Ease winter depression symptoms Likely modest benefit
small
11 meta-analyses n=18k Meta-analyzed 15–125 mg 4–48 wk #2/39
Ease depression tied to chronic pain Likely modest benefit
small
11 meta-analyses n=18k Meta-analyzed 15–125 mg 4–48 wk #2/39
Lower day-to-day anxiety Faint early signal
small
4 meta-analyses n=278 Meta-analyzed 0.6–300 mg 1–6 wk #9/48
Ease anxiety in older adults Faint early signal
small
4 meta-analyses n=278 Meta-analyzed 0.6–300 mg 1–6 wk #9/45
Reduce pre-competition anxiety Faint early signal
small
4 meta-analyses n=278 Meta-analyzed 0.6–300 mg 1–6 wk #9/45
Reduce daily stress Faint early signal
small
3 RCTs n=122 0.06–30 mg 4–8 wk
Improve everyday quality of life Not enough research
trivial
3 RCTs n=151 15.5–30 mg 4–6 wk
Buy well

Recommended Saffron products

Real products that dose Saffron where the research does, in a clean formulation, from brands we've audited. We only list ones we'd stand behind.

Chosen for adequate Saffron dosing vs. the studied range, a clean formulation (grade A–C), and independent brand-quality audits. Not sponsored.

Risk profile

Adverse events and known drug interactions

Safety events

angina severe
COVID-19 severe
diverticulitis severe
hypomania moderate
decreased platelet count moderate
decreased leukocyte count moderate
decreased red blood cell count moderate
burning sensation in kidney (history of kidney stone) mild

Drug interactions

Valproate moderate decreases effect
Isoniazid moderate decreases concentration
Rifampicin moderate decreases concentration
Gentamicin moderate decreases concentration
Escitalopram moderate decreases effect

Sources

  1. 1. Comparing the effects of saffron, lippia, and saffron-lippia combination on anxiety among candidates for coronary angiography. (2021)
  2. 2. Crocus Sativus for Insomnia: A Systematic Review and Meta-Analysis. (2022)
  3. 3. Evaluation of Saffron (Crocus Sativus L) Effects on Anxiety in Hospitalized Patients with Acute Coronary Syndrome. (2023)
  4. 4. The Effects of Combined Scutellaria and Saffron Supplementation on Mood Regulation in Participants with Mild-to-Moderate Depressive Symptoms: A Randomized, Double-Blind, Placebo-Controlled Study. (2025)
  5. 5. Effects of Saffron Extract Supplementation on Mood, Well-Being, and Response to a Psychosocial Stressor in Healthy Adults: A Randomized, Double-Blind, Parallel Group, Clinical Trial. (2020)
  6. 6. Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial. (2012)
  7. 7. Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study. (2013)
  8. 8. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. (2013)
  9. 9. Comparative efficacy and safety of Crocus sativus L. for treating mild to moderate major depressive disorder in adults: a meta-analysis of randomized controlled trials. (2018)
  10. 10. The efficacy of Crocus sativus (Saffron) versus placebo and Fluoxetine in treating depression: a systematic review and meta-analysis. (2019)

Generated August 14, 2026

Want personalized recommendations?

Show me what works for me